Accessibility Menu
Datatrak International logo

Datatrak International(OTC) DTRK

Current Price$0.28
Market Cap$7.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-100%
5 Year-97%
1 Year-66%
1 Month-31%
Datatrak International last closing stock price
MetricPriceDate
Last closeUSD 0.282026-07-23
Datatrak International stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+61.4%USD 0.172026-07-16
1 month-31%USD 0.402026-06-23
3 month-21.14%USD 0.352026-04-24
Year to date-25.41%USD 0.372025-12-31
1 year-65.86%USD 0.812025-07-23
3 year-23.86%USD 0.362023-07-24
5 year-96.51%USD 7.902021-07-23
Since inception-99.77%USD 118.001996-06-11

Datatrak International Financials at a Glance

Market Cap

$7.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.93M

Net Income (TTM)

-$888.57K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$0.28

Volume

10,000

Open

$0.28

Previous Close

$0.28

Daily Range

$0.28 - $0.30

52-Week Range

$0.17 - $1.63

Estimated Earnings Date

Mar 28, 2025

DTRK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Datatrak International

DATATRAK International, Inc. is a technology-driven company specializing in the clinical research industry. The company offers a comprehensive suite of services and solutions designed to enhance the efficiency of clinical trials.

Products and Services
  • DATATRAK ONE Unified Experience platform for clinical trial management
  • Specialized modules for trial planning, data capture, and patient management
  • Clinical Consulting Services for expert training and support
Growth Outlook
  • Strong demand for clinical trial technology solutions is expected to drive growth
  • Expansion into new markets and partnerships with healthcare organizations
  • Continued investment in product development to enhance service offerings
Financial Highlights
  • Recent quarterly revenue of $1,227,873 shows a solid market presence
  • Trailing twelve months (TTM) net profit margin stands at 37.27%
  • Current ratio of 1.81 indicates strong short-term financial health
DATATRAK International, Inc. has established itself as a key player in the healthcare information services sector. The flagship DATATRAK ONE platform integrates various functionalities, allowing clinical professionals to streamline trial processes effectively. The company serves a diverse clientele, including pharmaceutical firms and contract research organizations, which positions it well for future growth. The growth outlook remains positive, driven by increasing demand for innovative clinical trial solutions. The company's commitment to expanding its market reach and enhancing its product offerings is expected to yield significant benefits. Financially, recent quarterly results indicate a robust revenue stream, while the TTM net profit margin reflects effective cost management and operational efficiency. The current ratio further underscores the company's ability to meet short-term obligations, providing a solid foundation for future endeavors.
AI Generated • Jul 16, 2026

Industry

Health Care Technology

Employees

13

CEO

Alex Tabatabai

Headquarters

Mayfield Heights, OH 44124, US

DTRK Financials

Key Financial Metrics (TTM)

Gross Margin

81.16%

Operating Margin

29.38%

Net Income Margin

37.27%

Return on Equity

36.67%

Return on Capital

33.44%

Return on Assets

19.27%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

28.56M

Volume

10.00K

Avg. Volume

1.71K

Financials (TTM)

Gross Profit

$3.67M

Operating Income

-$1.48M

EBITDA

-$103.70K

Operating Cash Flow

-$2.75M

Capital Expenditure

-$8.51M

Free Cash Flow

-$11.25M

Cash & ST Invst.

$636.31K

Total Debt

$750.13K

Datatrak International Performance Analysis

Datatrak International annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 5,925,394-7.1%
20232023-12-31USD 6,184,2654.4%
20242024-12-31USD 6,685,2018.1%
20252025-12-31USD 7,191,1807.6%
Datatrak International sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12022-03-311.2%
Q22022-06-305.5%
Q32022-09-30-18.1%
Q42022-12-31-11.7%
Datatrak International annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.32205.3%
20232023-12-31USD 0.47N/A
20242024-12-31USD 0.33-29.6%
20252025-12-31USD 0.06-81.8%
Datatrak International sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12022-03-3170.4%
Q22022-06-30-165.1%
Q32022-09-309.6%
Q42022-12-31-0.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$1.23M

-22.8%

Gross Profit

$691.81K

-31.0%

Gross Margin

56.34%

N/A

Market Cap

$7.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$606.31K

N/A

Employees

13

N/A

Net Income

-$292.79K

+11.6%

EBITDA

-$223.74K

-94.4%

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Total Cash

$636.31K

-62.6%

Total Debt

$750.13K

-30.3%

Accounts Receivable

$810.55K

+68.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$750.13K

+2043.2%

Return on Assets

19.27%

N/A

Return on Invested Capital

17.86%

N/A

Free Cash Flow

-$9.14M

-1910.5%

Operating Cash Flow

-$1.23M

-275.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ISCOInternational Stem Cell Corporation
$0.31+10.71%
CYDXCYduct Diagnostics, Inc.
$2.70+0.00%
ESMCEscalon Medical Corp.
$0.20+0.00%
CTTHCTT Pharmaceutical Holdings, Inc.
$0.07+8.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About DTRK

What is the current price of Datatrak International?

Datatrak International is trading at $0.28 per share.

What is the 52-week range for Datatrak International?

Over the past 52 weeks, Datatrak International has traded between $0.17 and $1.63.

How much debt does Datatrak International have?

As of the most recent reporting period, Datatrak International reported total debt of $21.00K.

How much cash does Datatrak International have on hand?

Datatrak International reported $108.53K in cash and cash equivalents in its most recent financial results.

What is Datatrak International’s dividend yield?

Datatrak International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.